SCHEMBL4745343

SCHEMBL4745343

Cc1cc(Cl)c2ccc(Cl)cc2n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.72
NR4A2 P43354 1/20 0.68
MAPT P10636 4/20 0.59
LMNA P02545 1/20 0.56
CRHR1 P34998 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.47
ADORA1 P30542 1/20 0.47
KMT2A Q03164 2/20 0.45
MPO P05164 1/20 0.45
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
BCHE P06276 1/20 0.40
CHRM1 P11229 1/20 0.40
ACHE P22303 1/20 0.40
EPHX2 P34913 1/20 0.40
KDM4E B2RXH2 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492060 0.84 POLB (1.00) POLBNR4A2MAPTLMNACRHR1
SCHEMBL5258862 0.84 POLB (0.56) POLBNR4A2MAPTLMNACRHR1
SCHEMBL3648083 0.84 LMNA (0.72) POLBNR4A2MAPTLMNACRHR1
SCHEMBL4744795 0.81 POLB (0.68) POLBNR4A2MAPTLMNAADORA1
SCHEMBL858917 0.81 MAPT (0.56) POLBNR4A2MAPTLMNACRHR1
SCHEMBL438119 0.81 NR4A2 (1.00) POLBNR4A2MAPTADORA1KMT2A
SCHEMBL5024352 0.81 MAPT (0.56) POLBNR4A2MAPTLMNACRHR1
SCHEMBL9073054 0.81 MAPT (0.56) POLBNR4A2MAPTLMNAL3MBTL1
SCHEMBL6492059 0.81 POLB (0.68) POLBNR4A2MAPTLMNAADORA1
Bromide SCHEMBL9069438 0.79 MAPT (0.54) POLBNR4A2MAPTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013102936-A1 N-(3-((DIETHYLAMINO) METHYL)-4-HYDROXYPHENYL)-N-(QUINOLIN-4-YL) SULFONAMIDES FOR THE TREATMENT OF TUBERCULOSIS AND PROCESS OF PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-07-11 WO disclosed
WO-2013102936-A1 N-(3-((DIETHYLAMINO) METHYL)-4-HYDROXYPHENYL)-N-(QUINOLIN-4-YL) SULFONAMIDES FOR THE TREATMENT OF TUBERCULOSIS AND PROCESS OF PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-07-11 WO disclosed
WO-2008117079-A1 ANTIMICROBIAL COMPOUNDS BASED UPON 4-AMINOQUINOLINE HELPERBY THERAPEUTICS LIMITED (GB) 2008-10-02 WO disclosed
US-7220856-B2 Substituted quinoline CCR5 receptor antagonists SCHERING AKTIENGESELLSCHAFT (DE) 2007-05-22 US disclosed
EP-1373252-A1 CHEMICAL DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT Aventis Pharma S.A. (FR) 2004-01-02 EP disclosed
WO-2002076975-A1 CHEMICAL DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT AVENTIS PHARMA S.A. (FR) 2002-10-03 WO disclosed